Skip to main content
OpenTrials
Completed

NCT Number: NCT03274739

Maternal Diet, Body Mass Index Trajectories and Cardiometabolic Risk in Early Childhood

This study focused on evaluating the association between adherence to the Mediterranean diet during pregnancy and offspring longitudinal body mass index trajectories and cardiometabolic risk in early-childhood. This study is part of a secondary data analysis of the INMA (INfancia y Medio Ambiente-(Environment and Childhood)) Project.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • to be resident in one of the study areas
  • to be at least 16 years old
  • to have a singleton pregnancy
  • to wish to deliver in the reference hospital

Exclusion criteria

  • to not be fluent in Spanish or other regional languages.
  • to have followed a programme of assisted reproduction

Treatment and study plan

Primary outcomes

  1. Offspring's body mass index z-score trajectories

    Time frame: From birth to 4 years of age

  2. Child cardiometabolic risk score

    Time frame: At 4 years

Sponsors and collaborators

Lead sponsor

Barcelona Institute for Global Health

Other

Registry information

Official study title

Maternal Mediterranean Diet During Pregnancy in Association to Longitudinal Body Mass Index Trajectories and Cardiometabolic Risk in Early Childhood

Important dates

Study start
2004
Primary completion
2012
Study completion
2017
First posted
Sep 7, 2017
Registry last updated
Apr 20, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.